, /PRNewswire/ -- (Nasdaq: ), a leader in single cell and spatial biology, announced today that it has started shipping its new Xenium Prime Pan-Tissue and Pathways panel. The new panel features an enhanced chemistry to increase plex by an order of magnitude while delivering excellent per-gene sensitivity, improved specificity and spatial fidelity, integrated multimodal cell segmentation and industry-leading speed and throughput. "It's been awesome to see the early enthusiasm for the gene panel from our customers, who appreciate the product for both its high and its high ," said , Co-Founder and Chief Scientific Officer at 10x Genomics.
"Xenium Prime is an incredible product that delivers outstanding results across every metric that matters, including sensitivity, specificity and throughput. This is our fifth major product launch this year, as we continue to deliver ground-breaking innovations to help customers pursue ground-breaking discoveries." Key features of the new high-plex Xenium Prime assay include: The company will host a webinar to introduce the Xenium Prime Pan-Tissue and Pathways panel on at .
Interested attendees can 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems .
